Generic Drug Product Development: International Regulatory Requirements for Bioequivalence, 1st Edition (Paperback) book cover

Generic Drug Product Development

International Regulatory Requirements for Bioequivalence, 1st Edition

Edited by Isadore Kanfer, Isadore Kanfer, Leon Shargel, Leon Shargel

CRC Press

332 pages

Purchasing Options:$ = USD
Paperback: 9780367384371
pub: 2019-09-05
SAVE ~$14.99
Hardback: 9780849377853
pub: 2010-03-25
SAVE ~$36.00

FREE Standard Shipping!


Due to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that they are of the same quality and are therapeutically equivalent to the brand name alternative. However, many countries have limited resources to inspect and verify the quality of all drug products for sale in their country.  This title discusses the worldwide legislative and regulatory requirements for the registration of generic and multi-source drug products.

Table of Contents

Introduction. Australasia. Brazil. Canada. The European Union. India. Japan. South Africa. South America and Pan American Health Organization. Taiwan. Turkey. United States of America. The World Health Organization.

About the Editors

Isadore Kanfer, Leon Shargel

Subject Categories

BISAC Subject Codes/Headings:
MEDICAL / Pharmacology
SCIENCE / Chemistry / General